| Nov 5 |
AstraZeneca Shares Slide As Execs in China Face Fraud Investigation
|
| Nov 5 |
AstraZeneca stock falls amid fears of China probe
|
| Nov 5 |
AstraZeneca’s China business under spotlight amid fraud case
|
| Nov 5 |
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
|
| Nov 5 |
AstraZeneca shares fall as China probe intensifies
|
| Nov 5 |
AstraZeneca Stock Falls on China Probe Fears
|
| Nov 5 |
Market Chatter: Astrazeneca Shares Slump on Ongoing Probe Into Alleged Insurance Fraud
|
| Nov 5 |
AstraZeneca falls as fraud investigation reportedly expands in China (update)
|
| Nov 5 |
Viking Therapeutics Offers An Obesity Drug for Healthy Adults
|
| Nov 5 |
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
|
